139 related articles for article (PubMed ID: 2523865)
1. Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia.
Lowe J; Brown B; Hardie D; Richardson P; Ling N
Immunol Lett; 1989 Jan; 20(2):103-9. PubMed ID: 2523865
[TBL] [Abstract][Full Text] [Related]
2. CD23 antigen expression in CLL.
Gibson J; Neville S; Joshua D; Kronenberg H
Br J Haematol; 1989 Aug; 72(4):598. PubMed ID: 2528370
[No Abstract] [Full Text] [Related]
3. Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL).
Ling NR; Stevenson FK; Brown B
Clin Exp Immunol; 1991 Dec; 86(3):360-6. PubMed ID: 1721010
[TBL] [Abstract][Full Text] [Related]
4. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
Sarfati M; Fournier S; Christoffersen M; Biron G
Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.
Billaud M; Busson P; Huang D; Mueller-Lantzch N; Rousselet G; Pavlish O; Wakasugi H; Seigneurin JM; Tursz T; Lenoir GM
J Virol; 1989 Oct; 63(10):4121-8. PubMed ID: 2550660
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
9. CD21 is a ligand for CD23 and regulates IgE production.
Aubry JP; Pochon S; Graber P; Jansen KU; Bonnefoy JY
Nature; 1992 Aug; 358(6386):505-7. PubMed ID: 1386409
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia.
Geisler CH; Larsen JK; Hansen NE; Hansen MM; Christensen BE; Lund B; Nielsen H; Plesner T; Thorling K; Andersen E
Blood; 1991 Oct; 78(7):1795-802. PubMed ID: 1717071
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.
Tooze JA; Bevan DH
Clin Exp Immunol; 1991 Mar; 83(3):423-9. PubMed ID: 1825940
[TBL] [Abstract][Full Text] [Related]
12. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S
Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201
[TBL] [Abstract][Full Text] [Related]
13. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
[TBL] [Abstract][Full Text] [Related]
14. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
[TBL] [Abstract][Full Text] [Related]
15. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
[TBL] [Abstract][Full Text] [Related]
16. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts.
Fournier S; Tran ID; Suter U; Biron G; Delespesse G; Sarfati M
Leuk Res; 1991; 15(7):609-18. PubMed ID: 1830631
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic analysis of B-cells extracted from human periodontal disease tissue.
Gemmell E; Seymour GJ
Oral Microbiol Immunol; 1991 Dec; 6(6):356-62. PubMed ID: 1668249
[TBL] [Abstract][Full Text] [Related]
18. Synergy test for recognition of epitopes on soluble proteins; its application in the study of CD21 and CD23 antigens and their respective antibodies.
Ling NR; Brown B; Hardie D
J Immunol Methods; 1994 Jul; 173(1):11-7. PubMed ID: 7518487
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic heterogeneity of B cell chronic lymphocytic leukaemia.
Merson A; Brochier J
Immunol Lett; 1988 Dec; 19(4):269-71. PubMed ID: 3266609
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of CLL: high CD23 antigen and alpha IFN receptor expression are features of favourable disease and of cell activation.
Dadmarz R; Cawley JC
Br J Haematol; 1988 Mar; 68(3):279-82. PubMed ID: 2965599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
